How to Screen for Chronic Anhedonia in Treatment-Resistant Depression
How can clinicians identify chronic anhedonia in patients with treatment-resistant depression to inform suicide risk assessment?
Patients with treatment-resistant depression often continue to have substantial suicide risk despite ongoing care, and anhedonia is common enough that simply noting its presence may not be clinically discriminating. This study supports a practical approach that focuses on whether anhedonia has been present both historically and currently, using 2 simple MINI questions to identify a higher-risk subgroup.
-
Confirm that the patient meets treatment-resistant depression criteria
Apply the study definition of treatment-resistant major depressive disorder as nonresponse to 2 or more distinct antidepressants taken at suitable dosages for a sufficient time. Use this workflow in patients with a history of at least 1 major depressive episode, because the study's clinically relevant findings were derived from that population.
-
Ask about lifetime anhedonia beyond the past 2 weeks
Use the MINI depression module question A2a: Were you ever much less interested in most things or much less able to enjoy the things you used to enjoy most of the time, for two weeks? A yes response identifies historical anhedonia occurring at some point beyond the immediate 2-week window.
-
Ask about anhedonia in the past 2 weeks
Use the MINI depression module question A2b: In the past two weeks, were you much less interested in most things or much less able to enjoy the things you used to enjoy, most of the time? A yes response identifies recent or current anhedonia within the 2 weeks preceding assessment.
-
Classify the temporal pattern of anhedonia
Interpret A2a yes with A2b no as past anhedonia. Interpret A2b yes in a patient who reports the current depressive episode as the only depressive episode as acute anhedonia. Interpret both A2a yes and A2b yes, together with at least 1 lifetime depressive episode, as chronic anhedonia, reflecting anhedonic symptoms present both historically and currently.
-
Use chronic anhedonia as a suicide risk marker
In patients with treatment-resistant depression, treat chronic anhedonia as a marker of elevated suicidality rather than viewing all anhedonia as equivalent. In this study, patients with chronic anhedonia were 2.4-fold more likely to report suicidal ideation and 3.9-fold more likely to report a suicide attempt in the month prior to assessment than those with past or acute anhedonia.
-
Complete structured suicide assessment and increase follow-up attention
Pair chronic anhedonia screening with a validated suicide assessment tool rather than relying on symptom history alone. The article specifically notes that validated tools such as the Sheehan Suicidality Tracking Scale, combined with more frequent follow-up, may help with earlier identification and intervention in this higher-risk subgroup.
Clinical Considerations
- The study was cross-sectional and based on self-report diagnostic assessment, so chronic anhedonia should be interpreted as a correlate of suicidality rather than a proven causal factor.
- The chronic anhedonia classification captures temporal persistence of symptoms across history and current assessment but does not verify uninterrupted chronicity episode by episode.
- The study did not use a validated stand-alone anhedonia scale and could not distinguish anhedonia subtypes such as anticipatory and consummatory anhedonia.
- The sample came from a specialty mood and anxiety clinic and excluded individuals referred for adult ADHD treatment, which may limit generalizability.
Bottom Line
In treatment-resistant depression, asking whether anhedonia has been present both historically and in the past 2 weeks is a simple way to identify a subgroup at higher risk for suicidal ideation and recent suicide attempt.
